Webiobenguane I 131 (Rx) Brand and Other Names: Azedra Classes: Radiopharmaceuticals Dosing & Uses AdultPediatric Dosage Forms & Strengths solution for injection 555MBq/mL (15mCi/mL)... WebNCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) recommend high-specific-activity (HSA) iobenguane I 131 (AZEDRA) as a category 2A treatment option for patients with prior positive MIBG scan with locally unresectable or distant metastatic PPGL (secreting tumors).
Iobenguane I 131 - Drugs and Lactation Database …
http://www.radiopharmaceuticals.info/i-131-mibg.html WebMibg-131 Zur Diagnose Ge Healthcare . 18965.00.00 : Ge Healthcare Buchler Gmbh & Co. Kg . Germany [131i] Meta-Iodobenzylguanidine For Diagnostic Use Ge Healthcare . ... smart city green
An update on overall survival from a multi-center, open-label, …
WebAug 2, 2024 · The U.S. Food and Drug Administration today approved Azedra (iobenguane I 131) injection for intravenous use for the treatment of adults and adolescents age 12 and older with rare tumors of the adrenal gland (pheochromocytoma or paraganglioma) that cannot be surgically removed (unresectable), have spread beyond the original tumor site … WebPharmaceuticals, Inc. to include HSA iobenguane I 131 for the non-FDA approved use for the treatment of high-risk unresectable locally advanced or metastatic iobenguane scan-positive tumors, high-risk neuroblastoma, and gastroenteropancreatic neuroendocrine tumors (GEP-NETS) including carcinoid, based on the clinical evidence supporting this use. WebApr 3, 2024 · Rare side effects of Iobenguane I 131 include: None. Seek medical care or call 911 at once if you have the following serious side effects: Severe headache, confusion, slurred speech, arm or leg weakness, trouble walking, loss of coordination, feeling unsteady, very stiff muscles, high fever, profuse sweating, or tremors; Serious eye symptoms ... smart city hameln pyrmont